Gene Therapy Institute News
The future of gene therapy has arrived, and it's changing lives
A novel approach to gene therapy is improving lives in ways once thought impossible. Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a new platform to deliver the gene therapy precisely to specific are
How gene therapy changed everything for child born with AADC deficiency
Ohio State researchers deliver life-changing treatment for genetic disorder
Life-changing gene therapy expanding beyond neurological conditions
With treatments for conditions like Alzheimer's disease on the horizon, researchers seek to address eye disease and chronic illness.
$22 million NIH award will accelerate ‘CRISPR’ research at UC Berkeley, Ohio State
The National Institutes of Health (NIH) is incentivizing researchers to think beyond single applications of genome editing and to develop platform approaches that can be used to address multiple diseases.
Gene therapy may offer new treatment strategy for alcohol use disorder
Gene therapy might offer a one-time, sustained treatment for patients with serious alcohol addiction, also called alcohol use disorder, according to a new study led by Krystof Bankiewicz, MD, PhD.
Kristy Townsend, PhD, receives prestigious research award from W.M. Keck Foundation
The W.M. Keck Foundation awarded $1.2 million to a multi-center team, led by researchers at The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center, to explore the neural feedback loop between the brain and adipos
Health Talks: The latest in ALS research at Ohio State
In this video, physician-scientist Stephen Kolb, MD, PhD, discusses the latest discovery of a gene associated with ALS (amyotrophic lateral sclerosis) that will help explain how and why it causes the disease.
Study examines the possible role of KIF5A gene in ALS
“Our findings could lead to a better understanding of how ALS develops in people who have this mutation,” said principal investigator Stephen Kolb, MD, PhD, professor of neurology and biological chemistry and pharmacology at Ohio State.
De-Risking Cell And Gene Therapy Clinical Trials
Dr. Russell Lonser, Director of the Gene Therapy Institute, gives a historical overview and provides insight on planning for the future of gene therapy.
New Gene Therapy Institute positions Ohio State as a leader in translational science
Ohio State holds one of the largest first-in-human clinical trial portfolios in gene therapy and is one of the only institutions with most of its gene therapy trials delivering targeted gene therapy to the midbrain.
Gene therapy is changing lives today; tomorrow, it could change millions
Ohio State scientist is studying a novel gene therapy model that could lead to treatment for widespread neurological diseases.
Ohio State launches new Gene Therapy Institute
The Institute will coordinate existing strengths to accelerate the expansion of therapies.
Meetings & Events
Upcoming Meetings
There are no upcoming meetings.
Recent Meetings
There are no recent meetings.